Claims
- 1. A compound of the formula ##STR23## wherein R.sup.1 signifies hydrogen or methyl, R.sup.2 signifies ethyl, propyl, isopropyl, imidazol-2-yl, pyrazol-3-yl, thiazol-4-yl, thien-2-yl or t-butoxy, R.sup.3 signifies isobutyl, cyclohexylmethyl or benzyl, R.sup.4 and R.sup.5 each independently signify hydrogen, alkanoyl, which is optionally mono- or multiply-substituted by amino, monoalkylamino, dialkylamino, alkanoylamino, alkanoyloxyamino, carboxy, alkoxy or hydroxy, or an O-protecting group or together signify a cyclic O-protecting group, R.sup.6 signifies one of the groups ##STR24## and A signifies one of the groups ##STR25## wherein D signifies a methyne group or a nitrogen atom, R.sup.7 signifies alkyl, aryl or arylalkyl and R.sup.8 signifies hydrogen, alkyl, aryl or arylalkyl or R.sup.7 and R.sup.8 together with the two atoms to which they are attached signify aryl, heteroaryl, cycloalkenyl or heterocycloalkenyl, R.sup.9 signifies hydrogen or alkyl and R.sup.10 and R.sup.11 each independently signify alkyl, aryl, arylalkyl, cycloalkyl or the group
- --CH.sub.2 --X--R.sup.14 (e)
- or, together with the carbon atom to which they are attached, cycloalkyl or heterocycloalkyl, with the proviso that, where R.sup.9 signifies alkyl, R.sup.10 and R.sup.11 also signify alkyl, the dotted line can signify an additional bond, R.sup.12 signifies phenyl, substituted phenyl, benzyl or naphthyl and R.sup.13 signifies hydrogen, alkoxycarbonyalkyl, alkylcarbonylalkyl, cycloalkylcarbonylalkyl, heterocycloalkylcarbonylalkyl, arylcarbonylalkyl, aminocarbonylalkyl, substituted aminocarbonylalkyl, alkoxycarbonylhydroxyalkyl, alkylcarbonylhydroxyalkyl, cycloalkylcarbonylhydroxyalkyl, heterocycloalkylcarbonylhydroxyalkyl, arylcarbonylhydroxyalkyl, aminocarbonylhydroxyalkyl, substituted aminocarbonylhydroxyalkyl, dialkoxyphosphoroxyalkyl, diphenyloxyphosphoroxyalkyl, arylalkyl, alkoxycarbonylamino, arylalkoxycarbonylamino, alkylthioalkyl, alkylsulphinylalkyl or alkylsulphonylalkyl, with the proviso that R.sup.13 can not signify alkoxycarbonylamino or arylalkoxycarbonylamino when R.sup.12 signifies phenyl, benzyl or .alpha.-naphthyl, Y signifies the bivalent residue of optionally N- and/or .alpha.-methylated phenylalanine, cyclohexylalanine, tyrosine, O-methyltyrosine, .alpha.-naphthylalanine or homophenylalanine linked with Z at the N-terminal, Z signifies acyl, X signifies an oxygen or sulphur atom or the group --NH-- and R.sup.14 signifies hydrogen, alkyl, cycloalkyl, arylalkyl, cycloalkylalkyl, alkylcarbonyl, arylcarbonyl or arylalkylcarbonyl, in the form of an optically pure diastereomer, a diastereomeric racemate, or mixtures thereof as well as pharmaceutically usable salts thereof.
- 2. A compound in accordance with claim 1, wherein R.sup.2 signifies ethyl, propyl, isopropyl, thiazol-4-yl, thien-2-yl or t-butoxy, R.sup.4 and R.sup.5 each independently signify hydrogen, alkanoyl, which is optionally mono- or multiply-substituted cy carboxy, alkoxy or hydroxy, or an O-protecting group or together signify a cyclic O-protecting group, R.sup.12 signifies phenyl, substituted phenyl or naphthyl and R.sup.13 signifies hydrogen, alkoxycarbonylalkyl, alkylcarbonylalkyl, cycloalkylcarbonylalkyl, heterocycloalkylcarbonylalkyl, arylcarbonylalkyl, aminocarbonylalkyl, substituted aminocarbonylalkyl, alkoxycarbonylamino, arylalkoxycarbonylamino, alkylthioalkyl, alkylsulphinylalkyl or alkylsulphonylalkyl.
- 3. A compound in accordance with claim 2, wherein R.sup.2 signifies ethyl, propyl, or isopropyl or R.sup.4 and R.sup.5 each signify hydrogen, R.sup.7 and R.sup.8 each independently signify alkyl, aryl or arylalkyl or, together with the two atoms to which they are attached, aryl, heteroaryl, cycloalkenyl or heterocycloalkenyl and R.sup.14 signifies alkyl, cycloalkyl, arylalkyl, cycloalkylalkyl, alkylcarbonyl, arylcarbonyl or arylalkylcarbonyl.
- 4. A compound in accordance with claim 1, wherein R.sup.1 signifies hydrogen, R.sup.2 signifies propyl, imidazol-2-yl, thiazol-4-yl, thien-2-yl or t-butoxy, R.sup.3 signifies cyclohexylmethyl, R.sup.4 and R.sup.5 each independently signify hydrogen or alkanoyl, which is optionally mono-substituted by dialkylamino, carboxy or alkoxy, or together signify a cyclic O-protecting group, R.sup.6 signifies the group (a) or (b), A signifies the group (c) or (d), D signifies a methyne group, R.sup.7 signifies alkyl and R.sup.8 signifies hydrogen or alkyl or R.sup.7 and R.sup.8 together with the two atoms to which they are attached signify aryl, heteroaryl or cycloalkenyl, R.sup.9 signifies hydrogen or alkyl, R.sup.10 and R.sup.11 each independently signify alkyl or the group (e) or, together with the carbon atoms to which they are attached, cycloalkyl or heterocycloalkyl, R.sup.12 signifies phenyl, substituted phenyl, benzyl or naphthyl, R.sup.13 signifies alkylcarbonylalkyl, heterocycloalkylcarbonylalkyl, alkylcarbonylhydroxyalkyl, dialkoxyphosphoroxyalkyl, arylalkyl, alkylsulphinylalkyl or alkylsulphonylalkyl, Y signifies the bivalent residue of phenylalanine linked with Z at the N-terminal, Z signifies acyl, X signifies an oxygen atom and R.sup.14 signifies hydrogen or arylalkyl.
- 5. A compound in accordance with claim 4, wherein R.sup.1 signifies hydrogen, R.sup.2 signifies imidazol-2-yl, imidazol-4-yl or thiazol-4-yl, especially R.sup.3 signifies cyclohexylmethyl, R.sup.4 and R.sup.5 each independently signify hydrogen or alkanoyl, which is optionally mono-substituted by methoxy, or together signify the acetal of pivalic aldehyde, especially in each case hydrogen, R.sup.6 signifies the group (b), A signifies the group (c), R.sup.9 signifies hydrogen, R.sup.10 and R.sup.11 each independently signify alkyl or, together with the carbon atom to which they are attached, cycloalkyl, especially methyl, ethyl, cyclopropyl or cyclobutyl, R.sup.12 signifies phenyl or substituted phenyl, especially phenyl, and R.sup.13 signifies alkylcarbonylalkyl or alkylsulphonylalkyl, especially C.sub.1 -C.sub.4 -alkylcarbonylmethyl or C.sub.1 -C.sub.4 -alkylsulphonylmethyl.
- 6. A compound in accordance with claim 1, (S)-.alpha.-[(S)-.alpha.-[(t-Butylsulphonyl)methyl]hydrocinnamamido]-N-[(1S,2R,3S)-1-(cyclohexylmethyl)-3-cyclopropyl-2,3-dihydroxypropyl]-4-thiazolepropionamide.
- 7. A composition comprising a compound of claim 1, in an amount effective for the control or prevention of high blood pressure and cardiac insufficiency, and a therapeutically inert excipient.
- 8. A method for treating high blood pressure and cardiac insufficiency which comprises administering a compound of claim 1 in an amount effective for treating high blood pressure and cardiac insufficiency.
- 9. A compound in accordance with claim 1, (1R,2S)-1-[(S)-1-[[N-[(S)-.alpha.-[(t-butylsulphonyl)methyl]cinnamoyl]-L-histidyl]amino]-2-cyclohexylethyl]-2-cyclopropylethylene bis (methoxyacetate).
- 10. A compound selected from the group consisting of ##STR26## wherein R.sup.1 signifies hydrogen or methyl, R.sup.2 signifies ethyl, propyl, isopropyl, imidazol-2-yl, pyrazol-3-yl, thiazol-4-yl, thien-2-yl or t-butoxy, R.sup.3 signifies isobutyl, cyclohexylmethyl or benzyl, B is an amino protecting group and R.sup.6 signifies one of the groups ##STR27## wherein D signifies a methyne group or a nitrogen atom, R.sup.7 signifies alkyl, aryl or arylalkyl and R.sup.8 signifies hydrogen, alkyl, aryl or arylalkyl or R.sup.7 and R.sup.8 together with the two atoms to which they are attached signify aryl, heteroaryl, cycloalkenyl or heterocycloalkenyl, R.sup.9 signifies hydrogen or alkyl and R.sup.10 and R.sup.11 each independently signify alkyl, aryl, arylalkyl, cycloalkyl or the group
- --CH.sub.2 --X--R.sup.14 (c)
- or together with the carbon atom to which they are attached, cycloalkyl or heterocycloalkyl, X is an oxygen or sulphur atom or the group --NH-- and R.sup.14 signifies hydrogen, alkyl, cycloalkyl, arylalkyl, cycloalkylalkyl, alkylcarbonyl, arylcarbonyl or arylalkylcarbonyl, with the proviso that, where R.sup.9 signifies alkyl, R.sup.10 and R.sup.11 also signify alkyl.
Priority Claims (3)
Number |
Date |
Country |
Kind |
820/88 |
Mar 1988 |
CHX |
|
3469/88 |
Sep 1988 |
CHX |
|
4824/88 |
Dec 1988 |
CHX |
|
Parent Case Info
This is a division of application Ser. No. 07/318,576 filed Mar. 3, 1989, now U.S. Pat. No. 5,134,123.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
5134123 |
Branca et al. |
Jul 1992 |
|
Foreign Referenced Citations (2)
Number |
Date |
Country |
189203 |
Jan 1986 |
EPX |
0202577 |
Nov 1986 |
EPX |
Non-Patent Literature Citations (2)
Entry |
Luly et al. Chem. Abstracts 111:89768n, 1989. |
J. Med. Chem. 31, 2264-2276, 1988. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
318576 |
Mar 1989 |
|